18.03.2021 | Letter to the Editor Reply
Second Reply to: “Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?”
verfasst von:
Giovanni Corso, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2021
Einloggen, um Zugang zu erhalten
Excerpt
The divergent results in outcomes of metaplastic breast cancer (MBC) stimulate lively discussions and, sometimes, misunderstandings.
1,
2 This rare neoplastic form has some specific clinicopathological characteristics that are largely described and confirmed within the literature, but outcome data remain controversial. …